Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy (2021)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 62/992,071, filed Mar 19, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,525,137 | Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy In force · High confidence UsedRemaining | Avidity Biosciences, Inc. | In force | High confidence | ||
| US 12,049,629 | Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy In force · High confidence | Avidity Biosciences, Inc. | In force | High confidence | ||
| US 12,104,156 | Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy In force · High confidence | Avidity Biosciences, Inc. | In force | High confidence | ||
| US 12,529,056 | Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy In force · High confidence | Avidity Biosciences, Inc. | In force | High confidence | ||
| Application 19/267,387 | Compositions and Methods of Treating Facioscapulohumeral Muscular Dystrophy Pending Not granted | Avidity Biosciences, Inc. | Pending | Not granted |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Avidity Biosciences, Inc..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.